001     136134
005     20250325111549.0
024 7 _ |a 10.1002/mds.23318
|2 doi
024 7 _ |a pmid:20623690
|2 pmid
024 7 _ |a pmc:PMC2989455
|2 pmc
024 7 _ |a 0885-3185
|2 ISSN
024 7 _ |a 1531-8257
|2 ISSN
024 7 _ |a altmetric:542759
|2 altmetric
037 _ _ |a DZNE-2020-02456
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Minnerop, Martina
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Callosal tissue loss in multiple system atrophy--a one-year follow-up study.
260 _ _ |a New York, NY
|c 2010
|b Wiley
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2010-07-08
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2010-11-15
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1742897712_24043
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Multiple system atrophy (MSA) is a neurodegenerative disease not only affecting the basal ganglia, brainstem, cerebellum, and intermediolateral cell columns of the spinal cord but also the cerebral cortex. Clinically, cerebellar (MSA-C) and parkinsonian variants of MSA (MSA-P) are distinguished. We investigated 14 MSA patients (10 MSA-C, 4 MSA-P, men: 7, women: 7; age: 61.1 ± 3.3 years) and 14 matched controls (men: 7, women: 7; age: 58.6 ± 5.1 years) with voxel-based morphometry (VBM) to analyze gray and white matter differences both at baseline and at follow-up, 1 year later. Baseline comparisons between patients and controls confirmed significantly less gray matter in MSA in the cerebellum and cerebral cortex, and significantly less white matter in the cerebellar peduncles and brainstem. Comparisons of tissue-loss profiles (i.e., baseline versus follow-up) between patients and controls, revealed white matter reduction in MSA along the middle cerebellar peduncles, reflecting degeneration of the ponto-cerebellar tract as a particularly prominent and progressive morphological alteration in MSA. Comparisons between baseline and follow-up, separately performed in patients and controls, revealed additional white matter reduction in MSA along the corpus callosum at follow-up. This was replicated through additional shape-based analyses indicating a reduced callosal thickness in the anterior and posterior midbody, extending posteriorly into the isthmus. Callosal atrophy may possibly reflect a disease-specific pattern of neurodegeneration and cortical atrophy, fitting well with the predominant impairment of motor functions in the MSA patients.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2015-09-01
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Atrophy: pathology
|2 MeSH
650 _ 2 |a Brain Stem: pathology
|2 MeSH
650 _ 2 |a Cerebellum: pathology
|2 MeSH
650 _ 2 |a Corpus Callosum: pathology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Follow-Up Studies
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Image Processing, Computer-Assisted
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Multiple System Atrophy: pathology
|2 MeSH
700 1 _ |a Lüders, Eileen
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Specht, Karsten
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Ruhlmann, Jürgen
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Schimke, Nicole
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Thompson, Paul M
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Chou, Yi Y
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Toga, Arthur W
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Abele, Michael
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Wüllner, Ullrich
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Klockgether, Thomas
|0 P:(DE-2719)2810314
|b 10
|e Last author
773 1 8 |a 10.1002/mds.23318
|b : Wiley, 2010-07-08
|n 15
|p 2613-2620
|3 journal-article
|2 Crossref
|t Movement Disorders
|v 25
|y 2010
|x 0885-3185
773 _ _ |a 10.1002/mds.23318
|g Vol. 25, no. 15, p. 2613 - 2620
|0 PERI:(DE-600)2041249-6
|n 15
|q 25:15<2613 - 2620
|p 2613-2620
|t Movement disorders
|v 25
|y 2010
|x 0885-3185
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989455
856 4 _ |u https://pub.dzne.de/record/136134/files/DZNE-2020-02456_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/136134/files/DZNE-2020-02456_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:136134
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2810314
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2010
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MOVEMENT DISORD : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MOVEMENT DISORD : 2017
920 1 _ |0 I:(DE-2719)999999
|k Pre 2020
|l DZNE before 2020
|x 0
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies (Bonn)
|l Patient Studies (Bonn)
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)999999
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1136/jnnp.32.1.28
|2 Crossref
|o 10.1136/jnnp.32.1.28
999 C 5 |9 -- missing cx lookup --
|a 10.1136/jnnp.52.Suppl.78
|2 Crossref
|o 10.1136/jnnp.52.Suppl.78
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/117.2.235
|2 Crossref
|o 10.1093/brain/117.2.235
999 C 5 |9 -- missing cx lookup --
|a 10.1136/jnnp.57.9.1047
|2 Crossref
|o 10.1136/jnnp.57.9.1047
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/117.4.835
|2 Crossref
|o 10.1093/brain/117.4.835
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/121.4.589
|2 Crossref
|o 10.1093/brain/121.4.589
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awf117
|2 Crossref
|o 10.1093/brain/awf117
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2003.08.028
|2 Crossref
|o 10.1016/j.neuroimage.2003.08.028
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.21032
|2 Crossref
|o 10.1002/mds.21032
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2007.04.028
|2 Crossref
|o 10.1016/j.neuroimage.2007.04.028
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2005.12.006
|2 Crossref
|o 10.1016/j.neuroimage.2005.12.006
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-005-0708-0
|2 Crossref
|o 10.1007/s00415-005-0708-0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2004.11.022
|2 Crossref
|o 10.1016/j.neuroimage.2004.11.022
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-002-0734-0
|2 Crossref
|o 10.1007/s00415-002-0734-0
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awl021
|2 Crossref
|o 10.1093/brain/awl021
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-006-0325-6
|2 Crossref
|o 10.1007/s00415-006-0325-6
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0022-510X(98)00304-9
|2 Crossref
|o 10.1016/S0022-510X(98)00304-9
999 C 5 |9 -- missing cx lookup --
|a 10.1006/nimg.2001.0786
|2 Crossref
|o 10.1006/nimg.2001.0786
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2005.02.018
|2 Crossref
|o 10.1016/j.neuroimage.2005.02.018
999 C 5 |9 -- missing cx lookup --
|a 10.1093/cercor/bhi112
|2 Crossref
|o 10.1093/cercor/bhi112
999 C 5 |y 1995
|2 Crossref
|o Benjamini 1995
999 C 5 |9 -- missing cx lookup --
|a 10.1093/cercor/9.7.712
|2 Crossref
|o 10.1093/cercor/9.7.712
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.3732-07.2008
|2 Crossref
|o 10.1523/JNEUROSCI.3732-07.2008
999 C 5 |9 -- missing cx lookup --
|a 10.1136/jnnp.2006.104075
|2 Crossref
|o 10.1136/jnnp.2006.104075
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2007.05.028
|2 Crossref
|o 10.1016/j.neuroimage.2007.05.028
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1552-6569.2008.00273.x
|2 Crossref
|o 10.1111/j.1552-6569.2008.00273.x
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1552-6569.2008.00262.x
|2 Crossref
|o 10.1111/j.1552-6569.2008.00262.x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2009.05.013
|2 Crossref
|o 10.1016/j.neuroimage.2009.05.013
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroimage.2006.05.044
|2 Crossref
|o 10.1016/j.neuroimage.2006.05.044
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0006-8993(92)90178-C
|2 Crossref
|o 10.1016/0006-8993(92)90178-C
999 C 5 |y 1992
|2 Crossref
|o Costa 1992
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00415-002-0764-7
|2 Crossref
|o 10.1007/s00415-002-0764-7
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.10502
|2 Crossref
|o 10.1002/mds.10502
999 C 5 |9 -- missing cx lookup --
|a 10.1002/mds.20656
|2 Crossref
|o 10.1002/mds.20656
999 C 5 |y 1986
|2 Crossref
|t Cerebral cortex
|o Innocenti Cerebral cortex 1986
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000088526
|2 Crossref
|o 10.1159/000088526
999 C 5 |9 -- missing cx lookup --
|a 10.1136/jnnp.69.5.623
|2 Crossref
|o 10.1136/jnnp.69.5.623


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21